Brain stimulation not as effective as drugs for depression In a placebo-controlled trial, transcranial direct-current stimulation did not show non-inferiority compared with escitalopram and was associated with more adverse events.…
Steroid inhalers linked to increased risk of mycobacterial infection Use of steroid inhalers for asthma and chronic obstructive pulmonary disease increases the risk of mycobacterial infections, according to a study published in the European Respiratory Journal.…
Bisphosphonates and denosumab reduce bone density loss in ADT-treated men Drug interventions can reduce fracture risk in men who receive ADT, but further research is needed.…
FDA approves first biosimilar for cancer The US Food and Drug Administration (FDA) has approved a biosimilar of Avastin (bevacizumab) for multiple cancer indications.…
Increased uptake of biosimilars could save the NHS up to £300m a year NHS England has set out plans to accelerate and widen the NHS’s use of biosimilars to cut up to £300m a year from the drug bill by 2021.…
HRT not linked to early death, study concludes Hormone replacement therapy is not associated with all-cause, cancer or cardiovascular death, according to the results of an 18-year follow-up study.…
Romosozumab reduces fracture risk in postmenopausal women with osteoporosis Researchers find that the drug can be an effective treatment for women who are susceptible to fracture.…
Study lends support to genuine efficacy of antidepressants Findings show that the antidepressants citalopram and paroxetine have significant beneficial effects, clearly outperforming placebo.…
Limited evidence for use of gabapentinoids to treat chronic low back pain Analysis of randomised controlled trials assessing the use of gabapentinoids for chronic low back pain confirms that evidence on their use is limited and the drug should be used with caution. …
Boots bows to pressure to sell cheaper morning after pill High street pharmacy chain Boots announces it will sell a cheaper version of the morning after pill but issues BPAS with legal warning over its campaign.…